Clinical and echocardiographic predictors of reintervention after percutaneous or surgical treatment of rheumatic mitral stenosis: A systematic review.
S A Gómez-Gualdrón, J S Macias-Martinez, A M Pulido-Parra et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review examined clinical and echocardiographic predictors of outcomes following percutaneous or surgical treatment for rheumatic mitral stenosis. Fourteen studies were analyzed, revealing that factors such as pulmonary hypertension and unfavorable valvular anatomy are linked to adverse events. Notably, achieving a post-procedural mitral valve area ≥2 cm² correlates with a reduced risk of restenosis and cardiovascular events.
Key findings
- Pulmonary hypertension and unfavorable valvular anatomy are associated with adverse events or reintervention.
- Achieving a post-procedural mitral valve area ≥2 cm² is linked to a lower risk of restenosis.
- Immediate hemodynamic results are key determinants of prognosis after intervention.
Why it matters
Understanding the predictors of adverse outcomes in rheumatic mitral stenosis can enhance risk stratification and inform clinical decision-making, potentially improving patient management and outcomes following intervention.